文献速递瓣膜病与结构性心脏病

经导管主动脉瓣植入术后结构性瓣膜衰败的系统评价与荟萃分析

Structural valve deterioration after transcatheter aortic valve implantation.
PubMed 文献 · Heart · 2017-07-06

结果显示TAVI术后SVD的合并发生率为每年每万例患者28.08例(95%CI 2.46至73.44每100患者年),发生SVD者中12%接受了瓣膜再干预;证据确信度为中等。

要点

  • TAVI术后5年内结构性瓣膜衰败可能并不常见。
  • 合并SVD发生率为28.08/万患者年(95%CI 2.46–73.44/100患者年)。
  • 发生SVD者中12%接受了瓣膜再干预。

核心结论

  • TAVI术后5年内结构性瓣膜衰败可能是不常见事件。
  • 明确SVD的影响及瓣膜相关再干预需求,需要纳入大量患者并随访超过10年的研究。

研究设计与样本

  • 系统评价与荟萃分析,检索Medline、Embase、Cochrane系统评价数据库与Cochrane CENTRAL(2002年至2016年9月)。
  • 双人独立评估研究资格、提取数据并评估偏倚风险,采用GRADE系统评价证据质量,并用随机效应模型合并发生率。

主要发现

  • 各研究报告TAVI术后SVD发生率为每年每100患者年0至1.34例。
  • SVD合并发生率为每年每万例患者28.08例(95%CI 2.46至73.44每100患者年)。
  • 发生SVD者中12%接受了瓣膜再干预。
  • 因研究间存在不一致性,证据确信度为中等。

临床怎么用

  • 对TAVI术后患者,5年内SVD风险可能较低,但仍需随访监测瓣膜功能。
  • 对预期寿命较长的患者,现有证据尚不足以就SVD影响与再干预需求给出推荐。

局限性

  • 仅纳入观察性研究,研究间存在不一致性,证据确信度为中等。
  • 中位随访时间介于1.6至5年,缺乏超过10年的长期随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transcatheter aortic valve implantation (TAVI), widely used to treat high-risk patients with severe symptomatic aortic stenosis, has recently been extended to younger patients at lower operative risk in whom long-term durability of TAVI devices is an important concern. Therefore, we conducted a systematic review and meta-analysis of observational studies addressing the frequency of structural valve deterioration (SVD) after TAVI. METHODS: We searched Medline, Embase, Cochrane Database of Systematic Reviews, and Cochrane CENTRAL from 2002 to September 2016. We included observational studies following patients with TAVI for at least 2 years. Independently and in duplicate, we evaluated study eligibility, extracted data, and assessed risk of bias for SVD post-TAVI. Our review used the GRADE system to assess quality of evidence. We pooled incidence rates using a random effects model. RESULTS: Thirteen studies including 8914 patients, with a median follow-up between 1.6 and 5 years, reported an incidence of SVD post-TAVI between 0 to 1.34 per 100 patient years. The pooled incidence of SVD was 28.08 per 10 000 patients/year (95% CI 2.46 to 73.44 per 100 patient years). Of those who developed SVD, 12% underwent valve re-intervention. Confidence in the evidence was moderate due to inconsistency among studies. CONCLUSION: Structural valve deterioration is probably an infrequent event within the first 5 years after TAVI. Ascertaining the impact of SVD and the need for valve-related re-interventions to inform recommendations for patients with a longer life-expectancy will require studies including a large number of patients with longer follow-up (>10 years).

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Foroutan F, Guyatt GH, Otto CM, et al. Structural valve deterioration after transcatheter aortic valve implantation. Heart. 2017. PMID: 28684441. doi:10.1136/heartjnl-2017-311329

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。